


The objective is to achieve capital growth on a medium to long-term basis.
| Name | % Net Assets | 
|---|---|
| CF Walker Crips UK High Alpha Acc | 8.5% | 
| Close Enhanced Commodities | 7.5% | 
| Allian z RCM BRIC Stars C Acc | 7.0% | 
| AXA Framlington UK Growth Acc | 5.5% | 
| Schroders Strategic Bond A Inc | 5.3% | 
| AXA Framlington Biotech Fu nd Acc | 4.8% | 
| GlaxoSmithKline | 4.7% | 
| BP | 4.4% | 
| Barcap S&P Note 2 4/11/2009 6% | 3.8% | 
| BG Group | 3.3% | 
| Key | % Net Assets | 
|---|---|
| 8.5% | |
| 7.5% | |
| 7.0% | |
| 5.5% | |
| 71.5% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 31/01/2004 | 
|---|---|
| Fund Manager | Tony Yousefian | 
| TER | 1.58 (10-Jul-2012) | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | 500 | 
| Savings | 50 | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 1.29% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.07 | 
You are here: research